0001209191-23-052586.txt : 20231010
0001209191-23-052586.hdr.sgml : 20231010
20231010214929
ACCESSION NUMBER: 0001209191-23-052586
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231006
FILED AS OF DATE: 20231010
DATE AS OF CHANGE: 20231010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHAH BIMAL R.
CENTRAL INDEX KEY: 0001557394
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40388
FILM NUMBER: 231319330
MAIL ADDRESS:
STREET 1: C/O SPECTRUM PHARMACEUTICALS
STREET 2: 11500 SOUTH EASTER AVENUE, SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001815974
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851170950
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: JFL CAPITAL MANAGEMENT
STREET 2: 1017 RR 620 S, SUITE 107
CITY: LAKEWAY
STATE: TX
ZIP: 78734
BUSINESS PHONE: 737 203 5270
MAIL ADDRESS:
STREET 1: JFL CAPITAL MANAGEMENT
STREET 2: 1017 RR 620 S, SUITE 107
CITY: LAKEWAY
STATE: TX
ZIP: 78734
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-06
0
0001815974
Anebulo Pharmaceuticals, Inc.
ANEB
0001557394
SHAH BIMAL R.
C/O ANEBULO PHARMACEUTICALS, INC.
1017 RANCH ROAD 620 SOUTH, STE. 107
LAKEWAY
TX
78734
1
0
0
0
0
Stock Option (right to buy)
3.0271
2023-10-06
4
A
0
26097
0.00
A
2033-10-05
Common Stock
26097
26097
D
25% of the original number of shares vest on the first anniversary of October 6, 2023 (the "Vesting Commencement Date") and 2.0833% of the original number of shares vest at the end of each successive month following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date.
/s/ Bimal Shah
2023-10-10